Charles Schwab Investment Management Inc Marker Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.37 - $1.0 $9,827 - $26,562	-26,562 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $88,643 - $167,857	-47,151 Reduced 63.97%	26,562 $75,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $2.79 $15,412 - $25,444	9,120 Added 14.12%	73,713 $153,000
Q2 2019 Aug 09, 2019	BUY	$5.15 - $7.92 $332,653 - $511,576	64,593 New	64,593 $512,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $228M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.